Page
%P
-
Article
Bilateral papilledema on sunitinib therapy for advanced renal cell carcinoma
We report the case of a 59-year-old man with advanced renal cell carcinoma who developed bilateral papilledema while on therapy with sunitinib, a multi-targeted tyrosine kinase inhibitor (TKI). While papillede...